All Major Solid Tumors

Cancer Type

Tumor Tissue (FFPE)

Specimen Requirements

2-4 Working Days

Turnaround Time ¹

ACT Nonet™ is an RT-PCR customizable tissue panel. It covers 167 variants of 11 genes with U.S. FDA-approved targeted treatments. Including all NCCN guideline-recommended genes and high sensitivity (1~5% of DNA, 125 copies/reaction for RNA).

RT-PCR Customizable Tissue Panel

167

Variants

11

Specially Curated Genes

≥99.9%

Clinical sensitivity & specificity

Hallmarks of ACT Nonet™

Optimized

Save time, cost, and tissue slides

Novel

Include NCCN guideline recommended genes

Extensive

Genes with U.S. FDA-approved targeted treatments

Summary

•Thetest can detect the presence of 167 hotspot genetic alterations
•Limit of detection: 1-5% DNA mutation; 300 copies for RNA fusion
•Analytical sensitivity: >99.9%; Analytical specificity: >99.9%

Technical Specifications

RT-PCR

167 variants of 11 genes

Specimen Requirements2

Tumor tissue (FFPE)

Target Genes

ALK, ROS1, RET1, NTRK1/2/3, MET, EGFR, BRAF, KRAS, HER2

Documentation

Brochure
Download

Disclaimers / Footnotes

  1. Turnaround time starts from the date of receipt of approved samples at our CAP-accredited laboratory.
  2. Please refer to our specimen instructions.

Book a Test

Explore the immense possibilities and promising future of precision medicine. Together, let us unlock the power of genomic testing and personalize cancer care for the most effective treatment.

Get Started